Insights & Resources

Is your transaction a business combination or asset acquisition? Learn how ASC 805 guidance, the screen test and key differences shape reporting.

Learn how climate risk assessments help organizations quantify exposure, strengthen ERM, support capital planning and build long-term resilience.

Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.

Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.

Data center demand is rising, reshaping power access, water planning and community expectations. Learn what developers and operators should know.

Retailers, regulators and investors are demanding supply chain transparency. Learn how suppliers can turn compliance into a competitive advantage.

California extends the deadline to develop climate reporting regulations but maintains the 2026 reporting date for scope 1 and scope 2 emissions and climate risks.

Sustainability reporting can drive cost savings, enhance talent retention and mitigate risks. Explore its importance across a changing landscape.

Reinforce your sustainability strategy with practical steps that tie ESG initiatives to business value and measurable outcomes.

J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.

Although the SEC withdrew its climate disclosure rule, state and international regulations still require businesses to manage emissions and climate risks.

Download our white paper to learn how to even begin to measure and report GHG emissions.